Evaluation of an Ultraportable ECG Recording Device and Its Visualization Software for the Detection of Atrial Fibrillation (WITCARD)
Primary Purpose
Cardiovascular Illnesses
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
the use of the WitCard
the use of WitDisplayer
Sponsored by
About this trial
This is an interventional other trial for Cardiovascular Illnesses
Eligibility Criteria
Inclusion Criteria:
Patient, male or female, over 18 years of age, presenting to the cardiology-rhythmology department (consultations and hospitalizations) or to the emergency department of the Timone 2 Hospital for the management of suspicion of disorder heart rate in front of:
- Palpitations
- Dyspnoea, acute pulmonary edema, non-ischemic heart failure
- Malaise, lipothymia, syncope
Exclusion Criteria:
- Patients with clinical criteria that do not warrant the use of WitCard:
- Immediate vital risk whatever its nature
- Rhythmic urgency requiring treatment without delay: respiratory, circulatory or neurological distress
- Acute Coronary Syndrome
- Pregnant women
- Non-beneficiaries of a social security scheme
- Persons deprived of their liberty
- Patient participating in another study
- Patient in a period of exclusion determined by a previous study
- Patient under the protection of justice, under guardianship or under guardianship
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
witcard
Arm Description
Outcomes
Primary Outcome Measures
the ratio between the number of ECGWs that allowed a physician to make a rhythmic diagnosis (ECGW interpretable) and the total number of ECGWs recorded and visualized.
Secondary Outcome Measures
Full Information
NCT ID
NCT03975725
First Posted
May 28, 2019
Last Updated
June 3, 2019
Sponsor
Assistance Publique Hopitaux De Marseille
1. Study Identification
Unique Protocol Identification Number
NCT03975725
Brief Title
Evaluation of an Ultraportable ECG Recording Device and Its Visualization Software for the Detection of Atrial Fibrillation
Acronym
WITCARD
Official Title
Evaluation of an Ultraportable ECG Recording Device and Its Visualization Software for the Detection of Atrial Fibrillation
Study Type
Interventional
2. Study Status
Record Verification Date
June 2019
Overall Recruitment Status
Unknown status
Study Start Date
September 2019 (Anticipated)
Primary Completion Date
September 2022 (Anticipated)
Study Completion Date
March 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique Hopitaux De Marseille
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose is to demonstrate the usefulness of WitCard and WitDisplayer in the diagnosis of AF but more generally in the qualification of the heart rhythm and the diagnosis of cardiac arrhythmias.
The main objective is therefore to demonstrate that at least 90 +/- 0.03% of ECGWs are interpretable by a physician and the primary endpoint will therefore be the ratio of the number of ECGWs that allowed a physician to make a diagnosis. rhythmic (ECGW interpretable) and the total number of ECGW recorded and viewed.
The clinical trial as part of the CE medical device certification process for secondary objectives and ancillary studies will be required to assess the diagnostic performance of the WitCard + WitDisplayer system, the quality of the ECGW recorded by the WitCard, the the safety of using the WitCard, the technical performance of the WitCard ECG recorder, the ergonomics of the WitCard, and finally the performance of automatic cardiac rhythm classification algorithms.
Detailed Description
Monocentric, prospective, interventional study
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Illnesses
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
400 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
witcard
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
the use of the WitCard
Intervention Description
electrocardiogram (ECG)
Intervention Type
Other
Intervention Name(s)
the use of WitDisplayer
Intervention Description
a software to visualize, measure, annotate, comment, archive, and share the different ECGs acquired with the WitCard (ECGW) of different patients.
Primary Outcome Measure Information:
Title
the ratio between the number of ECGWs that allowed a physician to make a rhythmic diagnosis (ECGW interpretable) and the total number of ECGWs recorded and visualized.
Time Frame
9 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient, male or female, over 18 years of age, presenting to the cardiology-rhythmology department (consultations and hospitalizations) or to the emergency department of the Timone 2 Hospital for the management of suspicion of disorder heart rate in front of:
Palpitations
Dyspnoea, acute pulmonary edema, non-ischemic heart failure
Malaise, lipothymia, syncope
Exclusion Criteria:
Patients with clinical criteria that do not warrant the use of WitCard:
Immediate vital risk whatever its nature
Rhythmic urgency requiring treatment without delay: respiratory, circulatory or neurological distress
Acute Coronary Syndrome
Pregnant women
Non-beneficiaries of a social security scheme
Persons deprived of their liberty
Patient participating in another study
Patient in a period of exclusion determined by a previous study
Patient under the protection of justice, under guardianship or under guardianship
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
jean-claude deharo
Phone
04 91 69 89 24
Email
JeanClaude.DEHARO@ap-hm.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
jean-olivier ARNAUD
Organizational Affiliation
Assistance Publique Hopitaux De Marseille
Official's Role
Study Director
12. IPD Sharing Statement
Learn more about this trial
Evaluation of an Ultraportable ECG Recording Device and Its Visualization Software for the Detection of Atrial Fibrillation
We'll reach out to this number within 24 hrs